Literature DB >> 27798721

Tools, techniques, organisation and culture of the CADD group at Sygnature Discovery.

Steve A St-Gallay1, Colin P Sambrook-Smith2.   

Abstract

Computer-aided drug design encompasses a wide variety of tools and techniques, and can be implemented with a range of organisational structures and focus in different organisations. Here we outline the computational chemistry skills within Sygnature Discovery, along with the software and hardware at our disposal, and briefly discuss the methods that are not employed and why. The goal of the group is to provide support for design and analysis in order to improve the quality of compounds synthesised and reduce the timelines of drug discovery projects, and we reveal how this is achieved at Sygnature. Impact on medicinal chemistry is vital to demonstrating the value of computational chemistry, and we discuss the approaches taken to influence the list of compounds for synthesis, and how we recognise success. Finally we touch on some of the areas being developed within the team in order to provide further value to the projects and clients.

Keywords:  CADD; CRO; Computational chemistry; Drug Discovery

Mesh:

Year:  2016        PMID: 27798721     DOI: 10.1007/s10822-016-9989-x

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  7 in total

1.  A MATHEMATICAL CONTRIBUTION TO STRUCTURE-ACTIVITY STUDIES.

Authors:  S M FREE; J W WILSON
Journal:  J Med Chem       Date:  1964-07       Impact factor: 7.446

Review 2.  Creativity, innovation and lean sigma: a controversial combination?

Authors:  Craig Johnstone; Garry Pairaudeau; Jonas A Pettersson
Journal:  Drug Discov Today       Date:  2010-11-20       Impact factor: 7.851

3.  Expansion of chemical space for collaborative lead generation and drug discovery: the European Lead Factory Perspective.

Authors:  Anna Karawajczyk; Fabrizio Giordanetto; Jorg Benningshof; Daniel Hamza; Tuomo Kalliokoski; Kees Pouwer; Remy Morgentin; Adam Nelson; Gerhard Müller; Alexander Piechot; Dimitrios Tzalis
Journal:  Drug Discov Today       Date:  2015-09-30       Impact factor: 7.851

4.  Molecular Rift: Virtual Reality for Drug Designers.

Authors:  Magnus Norrby; Christoph Grebner; Joakim Eriksson; Jonas Boström
Journal:  J Chem Inf Model       Date:  2015-11-11       Impact factor: 4.956

5.  DataWarrior: an open-source program for chemistry aware data visualization and analysis.

Authors:  Thomas Sander; Joel Freyss; Modest von Korff; Christian Rufener
Journal:  J Chem Inf Model       Date:  2015-02-02       Impact factor: 4.956

6.  Jalview Version 2--a multiple sequence alignment editor and analysis workbench.

Authors:  Andrew M Waterhouse; James B Procter; David M A Martin; Michèle Clamp; Geoffrey J Barton
Journal:  Bioinformatics       Date:  2009-01-16       Impact factor: 6.937

7.  The ChEMBL bioactivity database: an update.

Authors:  A Patrícia Bento; Anna Gaulton; Anne Hersey; Louisa J Bellis; Jon Chambers; Mark Davies; Felix A Krüger; Yvonne Light; Lora Mak; Shaun McGlinchey; Michal Nowotka; George Papadatos; Rita Santos; John P Overington
Journal:  Nucleic Acids Res       Date:  2013-11-07       Impact factor: 16.971

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.